John L. Knopf

2013

In 2013, John L. Knopf earned a total compensation of $2.6M as Chief Executive Officer and President at Acceleron Pharma, a 35% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$300,000
Option Awards$1,696,442
Salary$400,000
Other$237,461
Total$2,633,903

Knopf received $1.7M in option awards, accounting for 64% of the total pay in 2013.

Knopf also received $300K in non-equity incentive plan, $400K in salary and $237.5K in other compensation.

Rankings

In 2013, John L. Knopf's compensation ranked 2,948th out of 12,286 executives tracked by ExecPay. In other words, Knopf earned more than 76.0% of executives.

ClassificationRankingPercentile
All
2,948
out of 12,286
76th
Division
Manufacturing
980
out of 4,612
79th
Major group
Chemicals And Allied Products
259
out of 1,466
82nd
Industry group
Drugs
176
out of 1,160
85th
Industry
Biological Products, Except Diagnostic Substances
25
out of 200
88th
Source: SEC filing on April 15, 2016.

Knopf's colleagues

We found four more compensation records of executives who worked with John L. Knopf at Acceleron Pharma in 2013.

2013

Matthew Sherman

Acceleron Pharma

Chief Medical Officer

2013

John Quisel

Acceleron Pharma

General Counsel

2013

Steven Ertel

Acceleron Pharma

Chief Operating Officer

2013

Kevin McLaughlin

Acceleron Pharma

Chief Financial Officer

In-depth

You may also like